The tweet was deleted by the author.
But we saved everything 🙂.
Former President Donald Trump has announced a groundbreaking agreement with pharmaceutical giant Pfizer to offer significant discounts on their drugs to the American public.
In a strategic move, a new government website named TrumpRx will be launched, enabling consumers to purchase medications directly, bypassing intermediaries. This initiative aims to reduce prescription costs substantially and fulfill Trump's promise to make healthcare more affordable.
Trump's latest initiative with Pfizer underscores the ongoing intersection of politics, healthcare, and regulatory oversight—an arena that has seen similar dynamics in prior legal and policy battles. Notably, the reversal by the South Carolina Supreme Court regarding access for the Trump DOJ, as detailed in the landmark court decision, highlighted the administration’s persistent efforts to reshape government processes. At the same time, high-profile figures navigating institutional shifts, such as the recent resignation of an ABC 20 anchor after internal controversy, illustrate the broader climate of change influencing both media and public policy.